SynthesisFrontiers in neurology2025
Association between oxidative stress-related IGF-1 and prognosis after ischemic stroke: a systematic review and meta-analysis.
Synthesis in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: Insulin-like growth factor-1 (IGF-1), an oxidative stress-related neurotrophic factor, has been investigated in stroke due to its potential roles in neuronal survival and vascular regulation. However, findings on its association with ischemic stroke and functional prognosis remain inconsistent. This review aimed to evaluate the association between circulating IGF-1 levels and (1) the risk of ischemic stroke and (2) post-stroke outcomes. Methods: We systematically searched EMBASE, MEDLINE, PubMed, Google Scholar, and the Cochrane Library from inception to June 2021, and updated the search to November 2025. Case-control or cohort studies reporting risks or odds ratios with 95% confidence intervals were included. Summary estimates were pooled using random-effects models when heterogeneity was substantial. Results: Our systematic literature search identified 10 articles. Four of these studies examined the association between IGF-1 and the risk of acute ischemic stroke, while the remaining six studies focused on the relationship between IGF-1 and unfavorable outcomes following acute ischemic stroke. No significant association was found between IGF-1 and ischemic stroke risk [risk ratio (RR) = 1.69, 95% confidence interval (CI) = 0.97-2.92, Conclusions: This systematic review and meta-analysis suggests that oxidative stress-related IGF-1 may be associated with long-term unfavorable outcomes following ischemic stroke, particularly beyond 1 year after onset. However, no significant associations were found with the incidence of acute ischemic stroke or short-term outcomes. Given the observational nature of the included studies and inconsistencies in adjustment for confounders, these findings should be interpreted cautiously. IGF-1 may serve as a potential prognostic biomarker for long-term functional decline after stroke, but further large-scale prospective studies are needed to clarify causality and clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.